Enhanced respiratory electron dissipation by immunometabolites promotes mycobacterial biofilm longevity
Kaushik PoddariD, Gunjan Tripathi, Snehal V. KhairnariD, Stuti SrivastaviD, Amitesh AnandiD
Abstract
Mycobacterium tuberculosis organizes as multicellular structures like granuloma and biofilm within human lungs and these lifestyles are critical for the pathophysiological outcomes. Granuloma has been the hallmark of M. tuberculosis infection and has been studied extensively. However, the metabolic interplay dictating biofilm development remains poorly understood. We show that supplementation of immunometabolites, nitrate or fumarate, extends mycobacterial biofilm lifespan dramatically. This longevity is enabled by suppression of dormancy regulons and maintenance of active metabolic state. These results establish that access to alternative electron acceptors directly influences mycobacterial biofilm fate. By linking dormancy suppression to prolonged structural integrity, our study identifies respiratory flexibility as a determinant of mycobacterial biofilm persistence. These findings reveal a central metabolic lever that dictates biofilm survival and open new avenues for targeting mycobacterial biofilms in clinical settings.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 1
- FWCI
- 4.95
- Field percentile
- top 5%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Adaptation of Mycobacterium tuberculosis to biofilm growth is genetically linked to drug tolerance
J. P. Richards, W. Cai, … A. K. Ojha·Antimicrobial Agents and ChemotherapyPeer-reviewed·Nov 1, 2019
- Title: Multimodal profiling reveals Mycobacterium tuberculosis restricts lung mitochondrial immunometabolism to promote pathogenesis
Hedwin Kitdorlang Dkhar, Prashant Bajpai, … Jyothi Rengarajan·bioRxiv·Apr 10, 2026
- Targeting Metabolic Vulnerabilities: Valinomycin Augments the Potency of Bioenergetic Inhibitors in Combatting Drug-Resistant and Dormant Mycobacterium tuberculosis
Arnab Roy, Satish Kushwah, … Nitin Pal Kalia·bioRxiv·Nov 23, 2025
- Mycobacterium abscessus biofilms produce an ECM and have a distinct mycolic acid profile
A. Dokic, E. Peterson, … A. Bhatt·bioRxiv·Mar 5, 2021
- Surface-Shaving Proteomics of Mycobacterium marinum Identifies Biofilm Subtype-Specific Changes Affecting Virulence, Tolerance and Persistence
K. Savijoki, H. Myllymäki, … M. Parikka·bioRxiv·Apr 26, 2021
- Granulysin antimicrobial activity promotes dormancy in Mycobacterium tuberculosis
Sarah Schmidiger, E. F. McCaffrey, … Damien Portevin·European Journal of ImmunologyPeer-reviewed·Aug 1, 2025